A therapeutic intervention for Alzheimer's disease using ginsenoside Rg3: its role in M2 microglial activation and non-amyloidogenesis.

Ahn, J W; Jang, S K; Jo, B R; Kim, H S; Park, J Y; Park, H Y; Yoo, Y-M; Joo, S S

Ahn, J W; Jang, S K; Jo, B R; Kim, H S; Park, J Y; Park, H Y; Yoo, Y-M; Joo, S S.

Afiliação

Ahn JW; College of Life Science, Gangneung-Wonju National University, Gangneung, Gangwon, Republic of Korea.
Jang SK; College of Life Science, Gangneung-Wonju National University, Gangneung, Gangwon, Republic of Korea.
Jo BR; Huscion MAJIC R&D Center, Seongnam, Gyeonggi, Republic of Korea.
Kim HS; College of Life Science, Gangneung-Wonju National University, Gangneung, Gangwon, Republic of Korea.
Park JY; College of Life Science, Gangneung-Wonju National University, Gangneung, Gangwon, Republic of Korea.
Park HY; Department of Chemical Engineering, Fergana Korea International University, Fergana, Uzbekistan.
Yoo YM; College of Pharmacy, Chung-Ang University, Dongjak-gu, Seoul, Republic of Korea.
Joo SS; College of Life Science, Gangneung-Wonju National University, Gangneung, Gangwon, Republic of Korea.

J Physiol Pharmacol ; 72(2)2021 Apr.

Article em En | MEDLINE | ID: mdl-34374655

Assuntos

Doença de Alzheimer; Ginsenosídeos; Doença de Alzheimer/tratamento farmacológico; Citocinas; Ginsenosídeos/farmacologia; Humanos; Microglia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ginsenosídeos / Doença de Alzheimer Limite: Humans Idioma: En Revista: J Physiol Pharmacol Assunto da revista: FARMACOLOGIA / FISIOLOGIA Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google